CH677796A5 - - Google Patents

Download PDF

Info

Publication number
CH677796A5
CH677796A5 CH2545/87A CH254587A CH677796A5 CH 677796 A5 CH677796 A5 CH 677796A5 CH 2545/87 A CH2545/87 A CH 2545/87A CH 254587 A CH254587 A CH 254587A CH 677796 A5 CH677796 A5 CH 677796A5
Authority
CH
Switzerland
Prior art keywords
monoclonal antibody
antibodies
flagella
antibody
type
Prior art date
Application number
CH2545/87A
Other languages
German (de)
English (en)
Inventor
Mark E Lostrom
Anthony W Siadak
Mae Joanne Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of CH677796A5 publication Critical patent/CH677796A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH2545/87A 1986-07-03 1987-07-03 CH677796A5 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (1)

Publication Number Publication Date
CH677796A5 true CH677796A5 (pt) 1991-06-28

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2545/87A CH677796A5 (pt) 1986-07-03 1987-07-03

Country Status (19)

Country Link
JP (1) JP2639422B2 (pt)
KR (1) KR910002373B1 (pt)
AT (1) AT399885B (pt)
AU (1) AU615162B2 (pt)
BE (1) BE1000743A3 (pt)
CH (1) CH677796A5 (pt)
DE (1) DE3722098C2 (pt)
DK (1) DK172840B1 (pt)
ES (1) ES2013321A6 (pt)
FR (1) FR2601458B1 (pt)
GB (1) GB2192185B (pt)
IE (1) IE60888B1 (pt)
IL (1) IL83047A (pt)
IT (1) IT1221940B (pt)
LU (1) LU86938A1 (pt)
NL (1) NL194961C (pt)
OA (1) OA08629A (pt)
PT (1) PT85247B (pt)
SE (1) SE506421C2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
AU654474B2 (en) * 1990-01-18 1994-11-10 Cura Nominees Pty Ltd Glycoalkaloids
JP2012516897A (ja) * 2009-02-04 2012-07-26 カロバイオス ファーマシューティカルズ インコーポレイティッド シュードモナス・エルギノーサ（ＰｓｅｕｄｏｍｏｎａｓＡｅｒｕｇｉｎｏｓａ）感染の治療のための抗生物質と抗体療法との組み合わせ
US8653242B2 (en) 2010-03-01 2014-02-18 Lostam Pharmaceuticals Ltd. Therapeutic antibodies against flagellated Pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
HU205630B (en) * 1985-06-06 1992-05-28 Genetic Systems Corp Process for producing monoclonal antibodys inhibiting exotoxine and toxic effect of pseudomonas aeruginosa and specific for them, celle lines producing them and pharmaceutical compositions
DE3689713T2 (de) * 1985-08-01 1994-07-07 Miles Inc Schützende Antikörper gegen serotypische Determinanten von flagellären Antigenen.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
SE506421C2 (sv) 1997-12-15
NL8701554A (nl) 1988-02-01
KR880001815A (ko) 1988-04-27
ES2013321A6 (es) 1990-05-01
IE60888B1 (en) 1994-08-24
ATA168387A (de) 1994-12-15
IL83047A0 (en) 1987-12-31
PT85247A (en) 1987-08-01
NL194961C (nl) 2003-09-02
DK336687D0 (da) 1987-06-30
GB8715347D0 (en) 1987-08-05
NL194961B (nl) 2003-05-01
GB2192185A (en) 1988-01-06
BE1000743A3 (fr) 1989-03-28
DK172840B1 (da) 1999-08-09
FR2601458A1 (fr) 1988-01-15
GB2192185B (en) 1991-01-16
OA08629A (en) 1988-11-30
AT399885B (de) 1995-08-25
LU86938A1 (fr) 1988-02-02
AU7495887A (en) 1988-01-07
JPS63102697A (ja) 1988-05-07
FR2601458B1 (fr) 1992-08-21
AU615162B2 (en) 1991-09-26
DE3722098A1 (de) 1988-03-03
JP2639422B2 (ja) 1997-08-13
PT85247B (pt) 1990-06-29
KR910002373B1 (ko) 1991-04-20
DE3722098C2 (de) 1998-06-04
SE8702734L (sv) 1988-01-04
IE871769L (en) 1988-01-03
IT8721163A0 (it) 1987-07-02
SE8702734D0 (sv) 1987-07-02
DK336687A (da) 1988-01-04
IT1221940B (it) 1990-08-31
IL83047A (en) 1992-12-01

Similar Documents

Publication Publication Date Title
AT400441B (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
DE60030274T2 (de) Aus ganzen zellen bestehender impfstoff, der staphylococcus aureus antigen enthält
DE69233012T2 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
DE60123036T2 (de) Anthrax-spezifisches antigen, impfstoffe die das antigen enthalten, anthrax-spezifische antikörper, und deren verwendungen
DE60026691T2 (de) Staphylococcus-antigene und impstoffe
EP0418827B1 (de) Impfstoff gegen die Lyme-Krankheit
DE69128273T2 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
AT398781B (de) Unsterbliche zellinie und deren verwendung
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
AT397803B (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
DE69329642T3 (de) Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
CH677796A5 (pt)
DE4493997C2 (de) Neue abgeschwächte Pseudomonas-Aeruginosa-Stämme
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE3685700T2 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
Marandi et al. Characterization of an outer membrane protein of Pasteurella multocida belonging to the OmpA family
DE3851630T2 (de) Antikörper gegen streptococcus.
DE69932719T2 (de) Humanisierte Antikörper zur Erkennung von Verotoxin II sowie Zelllinie zur Herstellung derselben
DE69935323T2 (de) Moraxella catharralis proteine
AT395591B (de) Humaner monoklonaler antikoerper, verfahren zu dessen herstellung, arzneimittel und hybridzelle
DE69012034T2 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
AT390192B (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
EP0387850B1 (de) Monoklonale, gegen ECA gerichtete Antikörper und ihre Verwendung
DE3587178T2 (de) Humaner monoklonaler antikoerper gegen pseudomonas aeruginosagegen pseudomonas aeruginosa produzierende hybridomen.
DE3853282T2 (de) Diagnostischer Test für Pseudomonas Aeruginosa Infektionen.

Legal Events

Date Code Title Description
PL Patent ceased